Background and study aims: Controversy exists about which colonoscopic technique is most sensitive for the diagnosis
of neoplasia in patients with ulcerative colitis. We compared new-generation narrow-band
imaging (NBI) to high-definition endoscopy (HDE) for the detection of neoplasia and
evaluated NBI for the differentiation of neoplastic from non-neoplastic mucosa.
Patients and methods: Randomized crossover trial in which patients with ulcerative colitis underwent both
NBI and HDE colonoscopy in random order with at least 3 weeks between the two procedures,
which were performed by different endoscopists. Lesions detected during the first
examination were left in situ in order to enable detection during the second examination
as well. Main outcome measures were (1) neoplasia detection, and (2) diagnostic accuracy
of NBI for differentiating neoplastic from non-neoplastic mucosa by using the Kudo
classification and vascular pattern intensity (VPI).
Results: Twenty-five patients were randomized to undergo HDE first and 23 to undergo NBI first.
Of 16 neoplastic lesions, 11 (69 %) were detected by HDE and 13 (81 %) by NBI (P = 0.727). Of 11 patients with neoplasia, 9 (82 %) were diagnosed by HDE and 8 (73 %)
by NBI (P = 1.0). The sensitivity, specificity, and accuracy of the Kudo classification were
76 %, 66 % and 67 %. Corresponding figures for VPI were 80 %, 72 %, and 73 %.
Conclusion: NBI does not improve the detection of neoplasia in patients with ulcerative colitis
compared to HDE. In addition, NBI proves unsatisfactory for differentiating neoplastic
from non-neoplastic mucosa.
References
- 1
Eaden J A, Abrams K R, Mayberry J F.
The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut.
2001;
48
526-535
- 2
Rutter M D, Saunders B P, Wilkinson K H et al.
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative
colitis.
Gastroenterology.
2006;
130
1030-1038
- 3
Collins P, Mpofu C, Watson A, Rhodes J.
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory
bowel disease.
Cochrane Database Syst Rev.
2006;
CD000279
- 4
Rutter M, Bernstein C, Matsumoto T et al.
Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining.
Endoscopy.
2004;
36
1109-1114
- 5
Rubin D T, Rothe J A, Hetzel J T et al.
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative
colitis?.
Gastrointest Endosc.
2007;
65
998-1004
- 6
Eaden J A, Mayberry J F.
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients
with inflammatory bowel disease.
Gut.
2002;
51 (Suppl 5)
V10-V12
- 7
Itzkowitz S H, Present D H.
Consensus conference: Colorectal cancer screening and surveillance in inflammatory
bowel disease.
Inflamm Bowel Dis.
2005;
11
314-321
- 8
Dekker E, Fockens P.
New imaging techniques at colonoscopy: tissue spectroscopy and narrow band imaging.
Gastrointest Endosc Clin N Am.
2005;
15
703-714
- 9
Kiesslich R, Fritsch J, Holtmann M et al.
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia
and colon cancer in ulcerative colitis.
Gastroenterology.
2003;
124
880-888
- 10
Kiesslich R, Goetz M, Lammersdorf K et al.
Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial
neoplasia in ulcerative colitis.
Gastroenterology.
2007;
132
874-882
- 11
Rutter M D, Saunders B P, Schofield G et al.
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative
colitis.
Gut.
2004;
53
256-260
- 12
Hurlstone D P, Sanders D S, Lobo A J et al.
Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection
and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective
evaluation.
Endoscopy.
2005;
37
1186-1192
- 13
Marion J F, Waye J D, Present D H et al.
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance
for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic
trial.
Am J Gastroenterol.
2008;
103
2342-2349
- 14
Gono K, Obi T, Yamaguchi M et al.
Appearance of enhanced tissue features in narrow-band endoscopic imaging.
J Biomed Opt.
2004;
9
568-577
- 15
Kuznetsov K, Lambert R, Rey J F.
Narrow-band imaging: potential and limitations.
Endoscopy.
2006;
38
76-81
- 16
Gheorghe C.
Narrow-band imaging endoscopy for diagnosis of malignant and premalignant gastrointestinal
lesions.
J Gastrointest Liver Dis.
2006;
15
77-82
- 17
Dekker E, van den Broek F J, Reitsma J B et al.
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia
in patients with longstanding ulcerative colitis.
Endoscopy.
2007;
39
216-221
- 18
Lichtiger S, Present D H, Kornbluth A et al.
Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
N Engl J Med.
1994;
330
1841-1845
- 19
Schlemper R J, Hirata I, Dixon M F.
The macroscopic classification of early neoplasia of the digestive tract.
Endoscopy.
2002;
34
163-168
- 20
Kudo S, Rubio C A, Teixeira C R et al.
Pit pattern in colorectal neoplasia: endoscopic magnifying view.
Endoscopy.
2001;
33
367-373
- 21
East J E, Suzuki N, Saunders B P.
Comparison of magnified pit pattern interpretation with narrow band imaging versus
chromoendoscopy for diminutive colonic polyps: a pilot study.
Gastrointest Endosc.
2007;
66
310-316
- 22
Schlemper R J, Riddell R H, Kato Y et al.
The Vienna classification of gastrointestinal epithelial neoplasia.
Gut.
2000;
47
251-255
- 23
Torlakovic E E, Gomez J D, Driman D K et al.
Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA).
Am J Surg Pathol.
2008;
32
21-29
- 24
Bossuyt P M, Reitsma J B, Bruns D E et al.
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD
initiative.
BMJ.
2003;
326
41-44
- 25
Machida H, Sano Y, Hamamoto Y et al.
Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study.
Endoscopy.
2004;
36
1094-1098
- 26
Srivastava A, Redston M, Farraye F A et al.
Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a
previously undescribed entity.
Am J Surg Pathol.
2008;
32
296-303
- 27
Rex D K, Helbig C C.
High yields of small and flat adenomas with high-definition colonoscopes using either
white light or narrow band imaging.
Gastroenterology.
2007;
133
42-47
- 28
Aschenbeck J, Adler A, Yenerim T et al.
Narrow-band versus white-light HDTV endoscopic imaging for screening colonoscopy:
a prospective randomized trial.
Gastroenterology.
2009;
136 (2)
410-416
- 29
van den Broek F J, Fockens P, van Eeden S et al.
Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomized comparison
of high resolution endoscopy and autofluorescence imaging for neoplasia detection;
and evaluation of narrow band imaging for classification of lesions.
Gut.
2008;
57
1083-1089
- 30
Matsumoto T, Kudo T, Jo Y et al.
Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia
in ulcerative colitis: a pilot study.
Gastrointest Endosc.
2007;
66
957-965
- 31
van den Broek F J, van Soest E J, Naber A H et al.
Combining autofluorescence imaging and narrow-band imaging for the differentiation
of adenomas from non-neoplastic colonic polyps among experienced and non-experienced
endoscopists.
Am J Gastroenterol.
2009;
104
1498-1507
- 32
Pohl J, Lotterer E, Balzer C et al.
Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine
chromoscopy: a randomised multicentre trial.
Gut.
2009;
58
73-78
- 33
Hoffman A, Kagel C, Goetz M et al.
Recognition and characterization of small colonic neoplasia with high-definition colonoscopy
using i-Scan is as precise as chromoendoscopy.
Dig Liver Dis.
2010;
42
45-50
- 34
Hurlstone D P, Sanders D S, Atkinson R et al.
Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can
we change the endoscopic management paradigm?.
Gut.
2007;
56
838-846
- 35
Rutter M D, Saunders B P, Wilkinson K H et al.
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help
predict cancer risk.
Gut.
2004;
53
1813-1816
- 36
Cairns S R, Scholefield J H, Steele R J et al.
Guidelines for colorectal cancer screening and surveillance in moderate and high risk
groups (update from 2002).
Gut.
2010;
59
666-689
E. DekkerMD, PhD
Department of Gastroenterology and Hepatology
Academic Medical Centre
University of Amsterdam
Meibergdreef 9
1105 AZ, Amsterdam
The Netherlands
Fax: +31-20-6917033
eMail: e.dekker@amc.uva.nl